BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21285394)

  • 1. Early reperfusion therapy affects inducibility, cycle length, and occurrence of ventricular tachycardia late after myocardial infarction.
    Piers SR; Wijnmaalen AP; Borleffs CJ; van Huls van Taxis CF; Thijssen J; van Rees JB; Cannegieter SC; Bax JJ; Schalij MJ; Zeppenfeld K
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):195-201. PubMed ID: 21285394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary artery reperfusion for ST elevation myocardial infarction is associated with shorter cycle length ventricular tachycardia and fewer spontaneous arrhythmias.
    Nalliah CJ; Zaman S; Narayan A; Sullivan J; Kovoor P
    Europace; 2014 Jul; 16(7):1053-60. PubMed ID: 24158256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of inducible very fast ventricular tachycardia (cycle length 200-230 ms) after early reperfusion for ST-segment-elevation myocardial infarction.
    Zaman S; Kumar S; Sullivan J; Narayan A; Thiagalingam A; Ross DL; Kovoor P
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):884-90. PubMed ID: 23995117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early reperfusion during acute myocardial infarction affects ventricular tachycardia characteristics and the chronic electroanatomic and histological substrate.
    Wijnmaalen AP; Schalij MJ; von der Thüsen JH; Klautz RJ; Zeppenfeld K
    Circulation; 2010 May; 121(17):1887-95. PubMed ID: 20404255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
    J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic catheter ablation for induced monomorphic ventricular tachycardia in patients with implantable cardioverter defibrillators as primary prevention.
    Hayashi T; Fukamizu S; Hojo R; Komiyama K; Tanabe Y; Tejima T; Soejima K; Nishizaki M; Hiraoka M; Ako J; Momomura S; Sakurada H
    Europace; 2013 Oct; 15(10):1507-15. PubMed ID: 23603305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Right ventricular dysfunction predisposes to inducible ventricular tachycardia at electrophysiology studies in patients with acute ST-segment-elevation myocardial infarction and reduced left ventricular ejection fraction.
    Thakkar JB; Zaman S; Byth K; Narayan A; Thiagalingam A; Chow C; Thomas SP; Sivagangabalan G; Farlow D; Barnett R; Kovoor P
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):898-905. PubMed ID: 25108742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of repeat programmed ventricular stimulation at electrophysiology study for arrhythmia prediction after acute myocardial infarction.
    Zaman S; Narayan A; Thiagalingam A; Sivagangabalan G; Thomas S; Ross DL; Kovoor P
    Pacing Clin Electrophysiol; 2014 Jul; 37(7):795-802. PubMed ID: 24666010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Zaman S; Sivagangabalan G; Narayan A; Thiagalingam A; Ross DL; Kovoor P
    Circulation; 2009 Jul; 120(3):194-200. PubMed ID: 19581496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of left ventricular ejection fraction and inducible ventricular tachycardia in ST-elevation myocardial infarction treated by primary angioplasty versus thrombolysis.
    Chong JJ; Ganesan AN; Eipper V; Kovoor P
    Am J Cardiol; 2008 Jan; 101(2):153-7. PubMed ID: 18178398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular tachyarrhythmias in patients receiving an implantable cardioverter-defibrillator for primary versus secondary prophylaxis indications.
    Manuchehry A; Agusala K; Montevecchi M; Kadish A; Passman R
    Pacing Clin Electrophysiol; 2011 May; 34(5):571-6. PubMed ID: 21208242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular arrhythmia inducibility predicts subsequent ICD activation in nonischemic cardiomyopathy patients: a DEFINITE substudy.
    Daubert JP; Winters SL; Subacius H; Berger RD; Ellenbogen KA; Taylor SG; Schaechter A; Howard A; Kadish A;
    Pacing Clin Electrophysiol; 2009 Jun; 32(6):755-61. PubMed ID: 19545338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.
    Gibson CM; Pride YB; Buros JL; Lord E; Shui A; Murphy SA; Pinto DS; Zimetbaum PJ; Sabatine MS; Cannon CP; Josephson ME;
    J Am Coll Cardiol; 2008 Feb; 51(5):546-51. PubMed ID: 18237683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
    Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of ventricular tachycardia and its electrophysiological substrate early after myocardial infarction: an ovine model.
    Hsieh CH; Chia EM; Huang K; Lu J; Barry M; Pouliopoulos J; Ross DL; Thomas SP; Kovoor P
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):1010-7. PubMed ID: 24036085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scar extent as a predictive factor of ventricular tachycardia cycle length after myocardial infarction: implications for implantable cardioverter-defibrillator programming optimization.
    Alexandre J; Saloux E; Lebon A; Dugué AE; Lemaitre A; Roule V; Labombarda F; Champ-Rigot L; Gomes S; Pellissier A; Scanu P; Milliez P
    Europace; 2014 Feb; 16(2):220-6. PubMed ID: 24186956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
    Rolf S; Haverkamp W; Borggrefe M; Breithardt G; Bocker D
    Europace; 2009 Mar; 11(3):289-96. PubMed ID: 19095687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early sustained ventricular arrhythmias complicating acute myocardial infarction.
    Piccini JP; Berger JS; Brown DL
    Am J Med; 2008 Sep; 121(9):797-804. PubMed ID: 18724970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of reperfusion time on inducible ventricular tachycardia early and spontaneous ventricular arrhythmias late after ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Kumar S; Sivagangabalan G; Thiagalingam A; West EB; Narayan A; Sadick N; Ong AT; Kovoor P
    Heart Rhythm; 2011 Apr; 8(4):493-9. PubMed ID: 21129504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of N-terminal pro-brain natriuretic peptide versus electrophysiologic study for predicting future outcomes in patients with an implantable cardioverter defibrillator after myocardial infarction.
    Yu H; Oswald H; Gardiwal A; Lissel C; Klein G
    Am J Cardiol; 2007 Aug; 100(4):635-9. PubMed ID: 17697820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.